BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24966078)

  • 21. [Personalized medicine in oncology: from hope to reality].
    Besse B; Soria JC
    Rev Prat; 2012 Feb; 62(2):245-6. PubMed ID: 22408877
    [No Abstract]   [Full Text] [Related]  

  • 22. It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.
    Bartelink H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():xxxv. PubMed ID: 21944037
    [No Abstract]   [Full Text] [Related]  

  • 23. Biomarkers and oncology: the path forward to a learning health system.
    Yu PP; Hoffman MA; Hayes DF
    Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological network modelling and precision medicine in oncology].
    Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
    Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systems medicine: a real approach for future personalized oncology?
    Roukos DH
    Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
    [No Abstract]   [Full Text] [Related]  

  • 28. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Precision oncology and molecular tumor boards].
    Mack E; Horak P; Fröhling S; Neubauer A
    Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
    Greillier L; Barlesi F
    Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
    [No Abstract]   [Full Text] [Related]  

  • 34. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalised cancer medicine.
    Jackson SE; Chester JD
    Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translating basic research in cancer patient care.
    Maugeri-Saccà M; De Maria R
    Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.